NF DISTRIBUTION CANADA LTD. – Trademark Portfolio
Entity Type: 03
NF DISTRIBUTION CANADA LTD. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include PEPTACE, REVITALX, DETOXITECH, BETACAREALL, and MIND PUBLISHING. The owner is based in COQUITLAM, BC.
1550 UNITED BOULEVARD
COQUITLAM, BC V3K 6Y7 , CA
Showing of trademarks Trademarks
Trademark Classifications
NF DISTRIBUTION CANADA LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does NF DISTRIBUTION CANADA LTD. have?
NF DISTRIBUTION CANADA LTD. has 15 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned, 6 cancelled.
What trademark classes does NF DISTRIBUTION CANADA LTD. file in?
NF DISTRIBUTION CANADA LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NF DISTRIBUTION CANADA LTD.'s most well-known trademarks?
NF DISTRIBUTION CANADA LTD.'s registered trademark portfolio includes well-known marks such as PEPTACE, REVITALX, DETOXITECH, BETACAREALL, and MIND PUBLISHING. These are among 7 currently registered trademarks in the portfolio.
What is NF DISTRIBUTION CANADA LTD.'s trademark registration success rate?
NF DISTRIBUTION CANADA LTD. has a 47% trademark registration rate, with 7 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.